Business Practice

Two members of the Drugs for Neglected Diseases initiative lay out how they improved access to Hep C treatment in Southeast Asia and beyond.

It's time for pharma fight back against fake news, says Ahmed Samy of eureka!digital.

Can ten23 health really make a difference to the planet while fully supporting its biopharma customers? We find out.

For 2022, we are very excited to launch The Medicine Maker Company of the Year Awards.

Nominations are now open for The Medicine Maker 2022 Power List!

Environmental, social, and governance (ESG) plans should be an integral part of any company that aims to thrive in today’s society.

Meet Ori Biotech’s Jason Foster. How did he transition to advanced therapy, and why did he end up in the UK?

Four courageous marketer-knights weigh in on what it takes to tilt against the social media windmills of pharma’s digital content kingdom.

Charlie Badham of 4D Pharma tells us his approach to social media in an age of outrage and tonal mixups.

Mike Rea of IDEA Pharma speaks frankly on the mud fights, echo chambers, and risks at play in the virtual forums of social media in 2021.